The overexpression of MDR-ABC transporters genes such as ABCB1, ABCG2, and ABCC2 has been reported to lead to interindividual difference in bioavailability of drugs, and it represents a potential mechanism of primary resistance to anti-cancer agents (5). The gene discussed is ABCG2; the disease is cancer.